Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
By D. Harold, R. Abraham, P. Hollingworth, R. Sims, A. Gerrish, M. Hamshere, J. S. Pahwa, V. Moskvina, Kimberley Dowzell, Amy J. Williams and 77 more. Nature Genetics, 2013
1,348 citations recorded by the source corpus.
View Paper: https://www.semanticscholar.org/paper/89670fb58cfe88627477dd83be8bdf7a138f2127
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Richard P. Mayeux
- Rudolph E. Tanzi
- Haohan Wang
- John Hardy
- Eric P. Xing
- C. Reitz
- V. Escott-Price
- J. Lambert
Citations in the corpus
- Alzheimer’s and Parkinson’s diseases: The prion concept in relation to assembled Aβ, tau, and α-synuclein (2015, unknown): “Genome-wide association studies (GWASs) have identified about 20 additional risk factors (119, 120).”
- Variable Selection in Heterogeneous Datasets: A Truncated-rank Sparse Linear Mixed Model with Applications to Genome-wide Association Studies (2017, background): “The 6th resides in WFDC1 and the 9th one is within GALNTL4, both are reported to be related with Alzheimer’s disease respectively [41], [42].”
- Linking Lipids to Alzheimer’s Disease: Cholesterol and Beyond (2011, background): “, some of which encode proteins that are linked to lipid metabolism (for example, clusterin (also known as apolipoprotein J) and cholesteryl ester transfer protein”
- Gene-Wide Analysis Detects Two New Susceptibility Genes for Alzheimer's Disease (2014, methodology): “Figure S4 QQ-plot of gene-wide p-values for all genes (A) and excluding previously reported[4-8] GWAS significantly associated genes ±0.”
- Epidemiology of Alzheimer Disease (2012, unknown): “Genome-wide association (GWA) studies have identified variants in CLU, PICALM, CR1, and BIN1 as putative susceptibility loci (Harold et al. 2009; Lambert et al. 2009; Seshadri et al. 2010).”
- The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data (2014, unknown): “Many common polymorphisms have now been found that increase genetic risk for AD (Harold et al. 2009; Lambert et al. 2009; Naj et al. 2011), age-related cognitive decline (Davies et al. 2012), schizophrenia (Almasy et al. 2008; Stefansson et al. 2009; Ripke et al. 2011; Rietschel et al. 2012),…”